EUVIMEDEUVIMED entdecken
Crossref

Endoscopic endonasal transcavernous surgery for knosp grade 3–4 growth hormone-secreting pituitary neuroendocrine tumors: surgical outcomes and predictors of biochemical remission

Ling Tian, Min Liu, Mei Luo, Cheng Zhou, Jian Gu, Jiajun Zeng, Qin Shen, Zhongyi Tong, Yi Jiang, Bihua Luo, Jian Lin, Zhifeng Sheng und 1 weitere

Neurosurgical Review · 2026

DOI: 10.1007/s10143-026-04467-8 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Neurosurgical Review, 2026. Verfasst von Ling Tian und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, The Second Xiangya Hospital of Central South University, No. 139 Renmin Middle Road, Changsha, 410011, China. Hauptthemen laut MEDLINE: Growth Hormone-Secreting Pituitary Adenoma, Neuroendocrine Tumors, Pituitary Neoplasms, Cavernous Sinus. Die Arbeit nennt 46 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Achieving biochemical remission in growth hormone-secreting pituitary neuroendocrine tumors (GH-PitNETs) with cavernous sinus invasion (Knosp grade 3-4) remains a significant surgical challenge. The objective was to evaluate the outcomes of the endoscopic endonasal transcavernous approach (transcavernous-EEA) and identify predictors of postoperative biochemical remission. This retrospective study included 50 patients with Knosp grade 3-4 GH-PitNETs. Patients were divided into two cohorts: Group 1 (prior to October 2020) received conventional EEA, while Group 2 (after October 2020) underwent transcavernous-EEA. The biochemical remission rate was significantly higher in Group 2 (64.7%) than in Group 1 (31.3%) (P = 0.027), with comparable surgery-related morbidity. In Group 2, preoperative IGF-1 (OR 0.984, 95% CI 0.969-0.999) and postoperative day 1 (POD1) GH levels (OR 0.241, 95% CI 0.076-0.760) were independently associated with biochemical remission in an exploratory multivariable analysis. Receiver operating characteristic curve analysis determined preliminary cutoff values of 587 ng/ml for preoperative IGF-1 (AUC 0.739, P = 0.007; Specificity 58.3%) and 2.185 ng/ml for POD1 GH (AUC 0.898, P < 0.001; Specificity 83.3%). Transcavernous-EEA was associated with higher biochemical remission during short-term follow-up in Knosp grade 3-4 GH-PitNETs without increasing surgical morbidity. Preoperative IGF-1 and POD1 GH levels may help stratify the likelihood of postoperative remission following this approach.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Growth Hormone-Secreting Pituitary AdenomaNeuroendocrine TumorsPituitary NeoplasmsCavernous SinusNeuroendoscopyHumansFemaleMaleRetrospective StudiesTreatment OutcomeMiddle AgedAdultInsulin-Like Growth Factor IHuman Growth HormoneRemission Induction

Stichwörter der Autor:innen

Biochemical remissionEndoscopic endonasal approachGH-PitNETsKnosp gradeTranscavernous

Substanzen

Insulin-Like Growth Factor IHuman Growth Hormone

Autor:innen und Institutionen

  • Department of Neurosurgery, The Second Xiangya Hospital of Central South University, No. 139 Renmin Middle Road, Changsha, 410011, China.
  • Department of Radiology, The Second Xiangya Hospital of Central South University, Changsha, China.
  • Department of Pathology, The Second Xiangya Hospital of Central South University, Changsha, China.
  • Clinical Nursing Teaching and Research Section, The Second Xiangya Hospital of Central South University, Changsha, China.
  • National Clinical Research Center for Metabolic Diseases, Department of Metabolism and Endocrinology, The Second Xiangya Hospital of Central South University, Changsha, China.
  • Health Management Center, National Clinical Research Center for Metabolic Diseases, Hunan Provincial Clinical Medicine Research Center for Intelligent, Changsha, China.

Zitieren

APA

Tian, L., Liu, M., Luo, M., Zhou, C., Gu, J., Zeng, J., Shen, Q., Tong, Z., Jiang, Y., Luo, B., Lin, J., Sheng, Z., & Peng, Y. (2026). Endoscopic endonasal transcavernous surgery for knosp grade 3–4 growth hormone-secreting pituitary neuroendocrine tumors: surgical outcomes and predictors of biochemical remission. Neurosurgical Review. https://doi.org/10.1007/s10143-026-04467-8

Vancouver

Tian L, Liu M, Luo M, Zhou C, Gu J, Zeng J, et al. Endoscopic endonasal transcavernous surgery for knosp grade 3–4 growth hormone-secreting pituitary neuroendocrine tumors: surgical outcomes and predictors of biochemical remission. Neurosurgical Review. 2026. doi:10.1007/s10143-026-04467-8

BibTeX
@article{Tian2026,
  author = {Tian, Ling and Liu, Min and Luo, Mei and Zhou, Cheng and Gu, Jian and Zeng, Jiajun and Shen, Qin and Tong, Zhongyi and Jiang, Yi and Luo, Bihua and Lin, Jian and Sheng, Zhifeng and Peng, Yong},
  title = {Endoscopic endonasal transcavernous surgery for knosp grade 3–4 growth hormone-secreting pituitary neuroendocrine tumors: surgical outcomes and predictors of biochemical remission},
  journal = {Neurosurgical Review},
  year = {2026},
  doi = {10.1007/s10143-026-04467-8}
}
Kostenlos starten →